Pnc Financial Services Group, Inc. Ionis Pharmaceuticals Inc Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 10,994 shares of IONS stock, worth $367,749. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,994
Previous 9,893
11.13%
Holding current value
$367,749
Previous $396,000
3.03%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding IONS
# of Institutions
411Shares Held
132MCall Options Held
829KPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA16.5MShares$551 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$474 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$384 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$345 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$263 Million5.48% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.75B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...